Table 1 Baseline characteristics
Normal weight | Overweight | Mild obesity | Moderate obesity + | All | ||
|---|---|---|---|---|---|---|
(n = 632) | (n = 1001) | (n = 840) | (n = 871) | p value | (n = 3344) | |
Mean age, yr. (SD) | 64.4 (19.1) | 66.5 (15.9) | 65.3 (14.8) | 62.6 (13.0) | p < 0.001 | 68.0 (15.7) |
Gender, n (%) | ||||||
Male | 304 (17.1) | 583 (32.8) | 486 (27.4) | 404 (22.7) | P < 0.001 | 1777 (100.0) |
Female | 328 (20.9) | 418 (26.7) | 354 (22.6) | 467 (29.8) | P < 0.001 | 1567 (100.0) |
CKD stages, n (%) | ||||||
Stage 1 | 46 (19.5) | 68 (28.8) | 59 (25.0) | 63 (26.7) | p = 0.2115 | 236 (100.0) |
Stage 2 | 60 (15.1) | 120 (30.2) | 100 (25.2) | 117 (29.5) | p < 0.001 | 397 (100.0) |
Stage 3A | 107 (17.7) | 180 (29.8) | 168 (27.8) | 149 (24.7) | p < 0.001 | 604 (100.0) |
Stage 3B | 181 (17.0) | 321 (30.1) | 271 (25.4) | 295 (27.6) | p < 0.001 | 1068 (100.0) |
Stage 4 | 181 (22.1) | 243 (30.0) | 190 (23.2) | 204 (24.9) | p = 0.01 | 818 (100.0) |
Stage 5 | 57 (25.8) | 69 (31.2) | 52 (23.5) | 43 (19.5) | p = 0.094 | 221 (100.0) |
PRD, n (%) | ||||||
Glomerulonephritis | 82 (19.2) | 140 (32.7) | 110 (25.7) | 96 (22.4) | p < 0.001 | 428 (100.0) |
Genetic renal disease | 58 (29.3) | 75 (37.9) | 36 (18.2) | 29 (14.7) | p < 0.001 | 198 (100.0) |
Diabetic nephropathy | 82 (10.3) | 162 (20.3) | 224 (28.0) | 331 (41.4) | p < 0.001 | 799 (100.0) |
Renovascular disease | 202 (19.9) | 342 (33.7) | 255 (25.1) | 216 (21.3) | p < 0.001 | 1015 (100.0) |
Uncertain | 48 (27.6) | 54 (31.0) | 35 (20.1) | 37 (21.2) | p < 0.001 | 174 (100.0) |
Others | 160 (21.9) | 228 (31.2) | 180 (24.7) | 162 (22.2) | p = 0.1309 | 730 (100.0) |
Diabetes, n (%) | ||||||
Yes | 167 (10.9) | 366 (23.9) | 428 (27.9) | 572 (37.3) | p < 0.001 | 1533 (100.0) |
No | 465 (25.7) | 634 (35.1) | 411 (22.7) | 299 (16.5) | p < 0.001 | 1809 (100.0) |
Cancer, N (%) | ||||||
Yes | 144 (19.9) | 234 (32.3) | 177 (24.5) | 169 (23.3) | p < 0.001 | 724 (100.0) |
No | 478 (18.9) | 739 (29.2) | 634 (25.0) | 682 (26.9) | p < 0.001 | 2533 (100.0) |
PVD, n (%) | ||||||
Yes | 70 (20.5) | 99 (29.0) | 83 (24.3) | 90 (26.3) | p = 0.1543 | 342 (100.0) |
No | 552 (18.9) | 874 (30.0) | 728 (25.0) | 761 (26.1) | p < 0.001 | 2915 (100.0) |
Chronic lung disease | ||||||
Yes | 143 (19.1) | 221 (29.5) | 170 (22.7) | 216 (28.8) | p < 0.001 | 750 (100.0) |
No | 489 (18.9) | 778 (30.0) | 669 (25.8) | 655 (25.3) | p < 0.001 | 2591 (100.0) |
CAD | ||||||
Yes | 150 (17.9) | 239 (28.6) | 221 (26.4) | 226 (27.0) | p < 0.001 | 836 (100.0) |
No | 482 (19.2) | 762 (30.4) | 619 (24.7) | 645 (25.7) | p < 0.001 | 2508 (100.0) |
All other CVD | ||||||
Yes | 247 (18.5) | 389 (29.1) | 319 (23.8) | 383 (28.6) | p < 0.001 | 1338 (100.0) |
No | 385 (19.2) | 612 (30.5) | 521 (26.0) | 488 (24.3) | p < 0.001 | 2006 (100.0) |
IRSD quintiles, n (%) | ||||||
Lowest | 109 (13.9) | 230 (29.3) | 205 (26.1) | 242 (30.8) | p < 0.001 | 786 (100.0) |
Low | 116 (17.1) | 215 (31.6) | 163 (24.0) | 186 (27.4) | p < 0.001 | 680 (100.0) |
Middle | 144 (19.8) | 209 (28.7) | 211 (29.0) | 164 (22.5) | p < 0.001 | 728 (100.0) |
High | 152 (22.6) | 197 (29.3) | 156 (23.2) | 168 (25.0) | p = 0.061 | 673 (100.0) |
Highest | 77 (24.8) | 97 (31.2) | 72 (23.2) | 65 (20.9) | p = 0.063 | 311 (100.0) |